Cytochrome P450 inhibitor, CYP17-IN-1, Purity ≥98%

Cat. No.: X24-08-YM394

Cytochrome P450 inhibitor, CYP17-IN-1, Purity ≥98%

Synonym: 2093317-51-0; 6-Fluoro-2-[(4-methylpyridin-3-yl)methyl]-3,4-dihydro-1H-[1]benzothiolo[2,3-c]pyridine

  • CAS Number: 2093317-51-0
  • Compound CID: 137635843
Product Size
1 mg; 5 mg; 10 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
CYP17-IN-1 is an effective cell metabolism inhibitor, that has the ability to prevent the pathway of metabolism by inhibiting cytochrome P450.
Molecular Weight
312.4
Molecular Formula
C18H17FN2S
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
CYP17-IN-1 is a metabolism inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of hormone-sensitive cancers, such as prostate cancer, by reducing androgen levels.
Storage
Store at -20ºC, and keep desiccated.
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0